-
Liver Cancer on the RiseLiver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.
by Sue Rochman
-
Gaps in End-of-Life CareRacial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
-
Online Discussions Reveal Little-Known Side EffectsAnalyzing online patient conversations could shed light on adverse drug reactions.
by Brad Jones
-
Is 3-D Mammography Better?A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
-
When Cancer Survivors Get Another CancerPatients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
-
Forward Look
An Overlooked Long-Term Side EffectQ&A with Patricia Ganz on chemotherapy-related nerve damage.
by Sue Rochman
-
Forward Look
Be Alert to Heart HealthRisk of stroke and heart disease increases after a cancer diagnosis.
by Robin Meadows
-
Forward Look
FDA Approves First Biosimilar Cancer TherapyNew product expected to be less expensive.
by Christina Bennett
-
Forward Look
Tracking Treatment Side Effects Benefits Cancer PatientsQuick response to symptoms improves quality of life and survival.
by Cameron Walker
-
Forward Look
Young Survivors at Risk for HPV-Related CancersStudy finds low vaccination rates among teen survivors.
by Kate Yandell
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
